1. Ovarian Carcinoma
Dr Khalid Sait FRCSC
Consultant Obstetrics and Gynecology
and Gynecological oncology

2. Evaluation of Ovarian Mass
• Preoperative assessment:
History Physical
Examination Tumour
markers Ultrasound
• Intra-operative assessment

3. Guideline
EORTIC, NCCN, NIH, SGO
• The more localized the disease appear ,
the more extensive the assessment
should be( STAGING)
Level II-3 A
• Optimal debulking for advance stage
provide a median survival benefit
Level II-b

4. Germ cell tumour

5. Endodermal sinus tumor
• Secrete AFP

6. Chemotherapy. BEP
• Cisplatin : 100mg/m i.v d1
• Bleomycin : 10-15mg d1-3(24h inf)
• Etoposide : 100mg/m i.v d1-3

8. SEX CORD-STROMAL
TUMORS( SCTS)

9. SEX CORD-STROMAL TUMORS
• SCTS are 15% of all malignant ovarian
neoplasm
• Hormonal secreting

10. Metastatic Tumors of Ovary